Results

Total Results: 316 records

Showing results for "vascular".

261. Archived: Tobacco Use Prevention: Counseling, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-prevention-counseling-1996
     January 01, 1996 - leading risk factor for myocardial infarction and coronary artery, cerebrovascular, and peripheral vascular

262. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/uM5P-6XpsqVfEC2axGnZaD
     November 16, 2020 - However, when analyses focused on major cardiovascular adverse events (combined outcome of cardio- vascular … cardiovascular adverse events (RR, 1.03 [95% CI, 0.71-1.50]; 27 trials; n = 10 402),82 or major cardio- vascular

263. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
     April 01, 2013 - Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics … Year-by-year analysis of cardio- vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE

264. Evidence Summary: Screening for Multifactorial Dyslipidemia: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-multifactorial-dyslipidemia/lipid-disorders-in-children-screening
     August 09, 2016 - Major lipids, apolipoproteins, and risk of vascular disease. JAMA . 2009;302(18):1993-2000. 43.

265. Screening for Obesity in Children and Adolescents: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DMDPeSf_nEUM-HrVrX6c7U
     June 20, 2017 - and psychological issues, asthma, obstructive sleep apnea, orthopedic problems, and adverse cardio­ vascular

266. untitled (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/QWUmLEKdwcYA-AKGp5dNaQ
     August 09, 2016 - No evidence was found on the ef- fectiveness of interventions in childhood or adolescence on cardio- vascular

267. Archived: Evidence Summary: Screening for Multifactorial Dyslipidemia: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-multifactorial-dyslipidemia/lipid-disorders-in-children-screening-july-2016
     August 09, 2016 - Major lipids, apolipoproteins, and risk of vascular disease. JAMA . 2009;302(18):1993-2000. 43.

268. Evidence Summary: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obstructive-sleep-apnea-in-adults-screening
     January 24, 2017 - Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea … Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients

269. Archived: Evidence Summary: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obstructive-sleep-apnea-in-adults-screening-january-2017
     January 24, 2017 - Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea … Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients

270. Effectiveness of Weight Management Interventions in Children: A Targeted Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/b5LjDb3-UoPV8LEWavJWB8
     February 01, 2010 - Although trial participants who re- ceived sibutramine developed cardio- vascular adverse effects (tachycardia … Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month

271. Evidence Summary: Thyroid Dysfunction: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary7/thyroid-dysfunction-screening
     October 28, 2014 - ǁ Circulatory events include ischemic heart disease, cerebrovascular accident, and peripheral vascular

272. 6Y7Rjecz Klegpj4Qqxmbc (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6Y7RjECz_KLeGpJ4qQxmBC
     January 01, 2015 - . ¶ Ischemic heart disease, cerebrovascular accident, and peripheral vascular disease.

273. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual

274. Screening for Ovarian Cancer: Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cTa7Hs56-yj4kCr7yXLdRm
     July 01, 1994 - Screening for Ovarian Cancer: Review R E V I E W S Screening for Ovarian Cancer Karen J. Carlson, MD; Steven J. Skates, PhD; and Daniel E. Singer, MD • Purpose: To critically review the available evidence for screening asymptomatic women for ovarian cancer with ultrasonography or the CA125 radioimmunoassay (C…

275. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/v1-breast-cancer-medications-for-risk-reduction--s
     May 06, 2002 - Differences in prevalence of and risk factors for subclinical vascular disease among black and white

276. Chemo and Couns/2nd instal (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
     July 01, 2002 - Differences in prevalence of and risk factors for subclinical vascular disease among black and white

277. PII: S0749-3797(01)00255-0 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
     January 01, 2001 - Hypertriglyceridemia as a cardio- vascular risk factor. Am J Cardiol 1998;81(suppl 1):7B–12B. 27.

278. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
     May 06, 2002 - Differences in prevalence of and risk factors for subclinical vascular disease among black and white

279. Evidence Summary: Atrial Fibrillation: Screening With Electrocardiography | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/atrial-fibrillation-screening-with-electrocardiography
     August 07, 2018 - hypertension, age ≥75 years [doubled], diabetes, stroke/transient ischemic attack/thromboembolism [doubled], vascular

280. Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary21/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling
     February 03, 2014 - Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial